Allogene Therapeutics, Inc.
FORMULATIONS AND PROCESSES FOR CAR T CELL DRUG PRODUCTS
Last updated:
Abstract:
Provided herein are formulations and drug product processes that can improve cell viability and minimize waste of the manufactured formulated cells for a drug product.
Status:
Application
Type:
Utility
Filling date:
3 Feb 2022
Issue date:
4 Aug 2022